The formate hydrogenlyase complex of Escherichia coli catalyses the cleavage of formate to CO 2 and H 2 and consists of a molybdoenzyme formate dehydrogenase-H, hydrogenase 3 and intermediate electron carriers. The structural genes of this enzyme complex are activated by the FhlA protein in the presence of both formate and molybdate ; ModE-Mo serves as a secondary activator. Mutational analysis of the FhlA protein established that the unique N-terminal region of this protein was responsible for formate-and molybdenum-dependent transcriptional control of the hyc operon. Analysis of the N-terminal sequence of the FhlA protein revealed a unique motif (amino acids 7-37), which is also found in ATPases associated with several members of the ABC-type transporter family. A deletion derivative of FhlA lacking these amino acids (FhlA9-2) failed to activate the hyc operon in vivo, although the FhlA9-2 did bind to hyc promoter DNA in vitro. The ATPase activity of the FhlA9-2-DNA-formate complex was at least three times higher than that of the native protein-DNA-formate complex, and this degree of activity was achieved at a lower formate level. Extending the deletion to amino acid 117 (FhlA167) not only reversed the FhlA N phenotype of FhlA9-2, but also led to both molybdenum-and formate-independence. Deleting the entire N-terminal domain (between amino acids 5 and 374 of the 692 amino acid protein) also led to an effector-independent transcriptional activator (FhlA165), which had a twofold higher level of hyc operon expression than the native protein. Both FhlA165 and FhlA167 still required ModE-Mo as a secondary activator for an optimal level of hyc-lac expression. The FhlA165 protein also had a twofold higher affinity to hyc promoter DNA than the native FhlA protein, while the FhlA167 protein had a significantly lower affinity for hyc promoter DNA in vitro. Although the ATPase activity of the native protein was increased by formate, the ATPase activity of neither FhlA165 or FhlA167 responded to formate. Removal of the first 117 amino acids of the FhlA protein appears to result in a constitutive, effector-independent activation of transcription of the genes encoding the components of the formate hydrogenlyase complex. The sequence similarity to ABC-ATPases, combined with the properties of the FhlA deletion proteins, led to the proposal that the N-terminal region of the native FhlA protein interacts with formate transport proteins, both as a formate transport facilitator and as a cytoplasmic acceptor.
INTRODUCTION
Escherichia coli catalyses the cleavage of intracellular formate to H # and CO # via the formate hydrogenlyase enzyme complex (FHL) (reviewed by Bo$ ck & Sawers, 1996) . This complex includes a formate dehydrogenase isoenzyme (FDH-H ; encoded by the fdhF operon), a hydrogenase isoenzyme (HYD3 ; encoded by the hyc operon), and intermediate electron carriers (also encoded by the hyc operon). FHL is only produced under anaerobic conditions and in the absence of alternative terminal electron acceptors, such as nitrate. Reduced levels of expression of the hyc operon under these conditions have been attributed to a reduced pool of intracellular formate (Rossmann et al., 1991) . This lack of available formate affects the transcriptional activator FhlA, as it requires formate as an effector molecule (Maupin & Shanmugam, 1990 ; Schlensog et al., 1994) .
Molybdenum is required for FHL activity and is present in the FDH-H protein as molybdopterin guanine dinucleotide (Boyington et al., 1997) . Molybdenum is transported in the form of molybdate by a high-affinity transporter encoded by the modABC operon (reviewed by Grunden & Shanmugam, 1997) . Previous studies have shown that the expression of both the hyc and fdhF operons also requires molybdenum for optimal transcription Hasona et al., 1998b) . ModE protein, originally characterized as a molybdatedependent repressor of the modABC operon (Grunden et al., 1996) , was also identified as a secondary transcriptional activator of the hyc operon (Self et al., 1999) . The FhlA protein has been proposed to serve as a molybdenum sensor (Hasona et al., 1998b) , possibly interacting with the product of molybdate activation by the MoeA protein (Hasona et al., 1998a) .
The FhlA protein has three distinguishable domains based, in part, on sequence similarity with other transcriptional activators, such as NtrC from E. coli (Nixon et al., 1986) and NifA from Klebsiella pneumoniae (Drummond et al., 1986) . The C-terminal region contains a helix-turn-helix motif which constitutes a DNA-binding domain ; this was confirmed by the DNA-binding activity of a C-terminal fragment of FhlA containing the amino acids 379-692 (Self, 1998 ; Leonhartsberger et al., 2000) . The central region of FhlA is conserved among all members of the NtrC\NifA family of activators and contains a nucleotide-binding motif (Weiss et al., 1991) : this region is probably responsible for formate-and DNA-dependent ATP hydrolysis and interaction with the σ&% form of RNA polymerase in the initiation of transcription (Hopper & Bo$ ck, 1995 ; Korsa & Bo$ ck, 1997) . The N-terminal segment of the FhlA protein appears to contain a region which modulates the transcriptional activity of the Cterminal segment. In many proteins of the NtrC family, the unique N-terminal region (of varying length) contains a receiver domain which must be phosphorylated by a cognate sensor-protein for activity (Keener & Kustu, 1988) . Some members of this family of activators are not known to be phosphorylated, and are presumed to interact with appropriate effector molecules directly. The N-terminal region of FhlA is one of the largest (380 aa), when compared to other response regulators of the NtrC family. The unique N-terminal region of the FhlA protein displays no significant sequence similarity to any known protein, and is not believed to be phosphorylated (Bo$ ck & Sawers, 1996) . Point mutations in the Nterminal region of FhlA lead to partial independence from formate (Korsa & Bo$ ck, 1997) and molybdenum (Self & Shanmugam, 2000) in the activation of the hyc operon. Based on these studies, it has been proposed that the N-terminal region of FhlA binds the effector molecule formate and may also interact with the product of the MoeA protein (activated molybdenum). Removal of the first 378 amino acids of the 692 aa FhlA protein led to a formate-independent transcriptional activator (Self, 1998 ; Leonhartsberger et al., 2000) . The N-terminal half of the protein was also shown to inhibit the ATPase activity of the C-terminal half of the protein and to inhibit the formate-dependent ATPase activity of the native protein. Since the FhlA protein has been proposed to interact with the MoeA product for optimum transcription of the hyc operon, and mutations in the unique N-terminal domain of FhlA lead to molybdenum-independence, it is possible that removing the N-terminal domain would also impart molybdenumindependence to the truncated FhlA protein. It is also not known which part of the nearly 400 aa N-terminal segment of the protein is essential for formate-and molybdenum-dependence for hyc activation. Therefore, several deletion derivatives extending to varying lengths of the N-terminal domain of FhlA were constructed to identify the critical region(s) responsible for effectorindependence, and the results of this study are reported here.
METHODS
Bacterial strains. The bacterial strains, phages and plasmids used in this study are detailed in Table 1 . All strains are derivatives of Escherichia coli K-12. Media and growth conditions. Media used for bacterial growth were as described by Rosentel et al. (1995) . L-broth (LB ; Miller, 1972) was supplemented with glucose (0n3 %), sodium formate (30 mM), sodium molybdate (1 mM) or sodium nitrate (30 mM). Antibiotics were added to the media, as required, at the following concentrations : 100 µg ampicillin ml − " ; 30 µg tetracycline ml − " ; 50 µg chloramphenicol ml − " (plates), 10 µg chloramphenicol ml − " (broth) ; 50 µg kanamycin ml − ". Transduction with phages P1 and λ was performed as described by Grunden et al. (1996) . Genetic and molecular experiments were performed essentially as previously described (Self et al., 1999) . Plasmids pWS2, pWS164 and pWS165 are derivatives of the low-copy vector pACYC184. Plasmid pWS167 is a derivative of pT7-7. For experiments involving pcnB mutant (Lopilato et al., 1986) , the appropriate fhlA + and fhlA165 DNAs were transferred to plasmid vector pBR322 in the construction of pWS3 and pWS165-2, respectively. Plasmid pWS165-2 also carries the gene for spectinomycin resistance from pSJS1240 (Kim et al., 1998) . Isolation of N-terminal deletion fhlA alleles. Internal deletion mutations within the fhlA gene were isolated by Bal31 nuclease treatment of pWS2 (Self & Shanmugam, 2000) after HpaI restriction endonuclease hydrolysis. HpaI hydrolyses pWS2 approximately in the centre of the DNA encoding the unique N-terminal region of the FhlA protein. The reactions were terminated by the addition of ethanol (70 % final concn) after 5, 10 and 15 min of nuclease treatment. The DNA was precipitated and subsequently ligated with T4 DNA ligase.
The ligation mixture was transformed into strain SE1174 (fhlA : :Tn10), and colonies expressing FDH-H activity were selected by the dye-overlay procedure as described by Lee et al. (1985) . Plasmids from selected clones were isolated and the size of the deletion was determined using restriction endonucleases. Three plasmids with a deletion of 1 kb were selected for further analysis. The extent of the deletion in each mutant fhlA allele was determined by sequencing the DNA using the Sanger dideoxy sequencing method (Sanger et al., 1977 ; Sequenase version 2n0 DNA sequencing kit). This procedure yielded fhlA alleles fhlA164, fhlA165 and fhlA166 (plasmids pWS164, pWS165 and pWS166, respectively ; Fig. 1 ). fhlA167 was isolated after removing the fhlA DNA as a PflMI-SmaI fragment and cloning it into a SmaI-digested vector, pT7-7. This construct, pWS41, carries a deletion of the first 117 aa of the N-terminus, and an extra 7 aa in the Nterminus derived from the vector DNA sequence (MARIRAL) which also provided the translation start site. Plasmid pWS167 was constructed by inserting a chloramphenicol-resistance gene cartridge into the ScaI site of pWS41. The fhlA167 allele DNA was sequenced to confirm the deletion. DNA sequences were analysed using  software (Riverside Scientific).
For the construction of pWS9-2, plasmid pWS9 was modified by introducing a chloramphenicol-resistance gene cartridge from plasmid pBR325 into the SspI-DraI sites, to generate pWS9-1, followed by PCR-mediated deletion of the fhlA DNA corresponding to amino acids 7-37 of the FhlA protein.
The fhlA gene on both sides of the deletion was amplified using two primer pairs (pair one, 5h-AAATGTCATATACACCG-ATGGTAAAGCGTTCTGCGCTCGCCG-3h and 5h-GACT-TCGCTGACCAGTTCGTCCATA-3h ; pair two, 5h-CGAG-CGCAGAACGCTTTACCATCGGTGTATATGACATT-TTGTTC-3h and 5h-TGTGGATAACCGTATTACCGCCT3h). The PCR products were ligated together to create the deletion derivative (plasmid pWS9-2), and the PCR-amplified region was sequenced to confirm that the fhlA gene in plasmid pWS9-2 did not carry any additional mutations, besides the intended deletion.
Purification of the FhlA165 protein.
Purification of the FhlA165 protein was essentially as described for the native FhlA protein by Schlensog et al. (1994) . Briefly, pWS16, which carries the fhlA165 allele under the control of phage T7 promoter, was constructed by ligating a 1n4 kb BstBI-ClaI fragment from pWS165 into the ClaI site in the expression vector pT7-7 (Tabor & Richardson, 1985) . Fresh transformants of BL21(DE3) with pWS16 were grown in 1 litre of LB with ampicillin in a 2n8 litre Fernbach flask at 37 mC with shaking (225 r.p.m.). When the culture reached OD %#! 0n7 (Spectronic 710 spectrophotometer), IPTG was added (0n34 mM final concn) and the culture was incubated at 37 mC with shaking (225 r.p.m.) for an additional 3 h. Cells were harvested and washed once with Tris buffer (50 mM Tris, pH 8n0; 0n5 mM EDTA ; 1 mM benzamidine ; 1 mM DTT). The cells were then resuspended in 12 ml Tris buffer and broken by passage through a French pressure cell [20 000 p.s.i. (138 MPa)]. All subsequent steps were carried out at 4 mC. The crude extract was centrifuged at 30 000 g for 30 min, and the supernatant (14 ml) was further clarified by centrifugation for 2 h at 120 000 g. Ammonium sulfate (37% saturation) was added to the supernatant, and the proteins were precipitated for 30 min. The sample was then centrifuged for 30 min at 30 000 g, and the pellet was dissolved in 1n2 ml Tris buffer. This sample was dialysed overnight in 1 litre Tris buffer. Unlike the wild-type FhlA protein, which precipitated out of solution at this step (Schlensog et al., 1994) , the FhlA165 remained soluble. This dialysed sample was analysed by chromatography, using a 40 ml heparin-agarose affinity column (Pharmacia Biotech). The column matrix was washed with Tris buffer and the proteins were eluted with a linear gradient of KCl (0-0n5 M). FhlA165-containing fractions, as determined by SDS-PAGE analysis, were pooled and dialysed overnight in Tris buffer. Further purification of FhlA165 was achieved using a 12 ml Q-Sepharose column (Pharmacia) and a linear KCl gradient (0-0n4 M). The FhlA165 protein eluted at approximately 0n3 M KCl, and was determined to be pure based on SDS-PAGE analysis. Fractions containing the FhlA165 protein were pooled and dialysed overnight in Tris buffer (25 mM, pH 7n5) with 1 mM EDTA and 50 % glycerol (v\v). The FhlA165 protein was stored at k20 mC. FhlA167 and FhlA9-2 proteins were purified essentially as described for FhlA165. However, the two proteins obtained after the Q-Sepharose step were subjected to further chromatography on a Q-Sepharose column with sodium citrate as the eluent. Both proteins eluted at a citrate concentration of 0n15 M. The pure proteins were dialysed against Tris buffer (50 mM, pH 7n5) and stored on ice. Freshly prepared proteins were used immediately. Purification of native FhlA protein. The purification procedure similar to the one used for FhlA165 protein led to the characteristic precipitation of the native protein during dialysis after the ammonium sulfate precipitation step (Schlensog et al., 1994) . The FhlA protein required high salt (0n2 M KCl) to remain in solution ; thus, it may not have been present in the native form. In addition, most of the FhlA protein produced upon expression from a T7 promoter was present in inclusion bodies. Therefore, the conditions used for expression of fhlA + and purification of the native FhlA were modified, and the method is described below. The fhlA + gene was cloned into the expression vector pT7-7, by removing a 2n4 kb SpeI-ClaI fragment from plasmid pSE133 (Sankar et al., 1988) and ligating this DNA to a 2n4 kb XbaI-ClaI fragment from pT7-7 (Tabor & Richardson, 1985) . The resultant plasmid, pWS9, carried the fhlA gene under the control of phage T7 gene 10 promoter. Fresh BL21(DE3) transformants of pWS9 were inoculated into 1 litre LB containing ampicillin, in a 2n8 litre Fernbach flask. The culture was grown with shaking (225 r.p.m.) at 37 mC until an OD %#! of 0n7 was reached. IPTG was added (0n5 mM final concn) to the culture, and incubation was continued at 23 mC with shaking (225 r.p.m.) for an additional 6 h. Incubating the culture at this temperature allowed a larger fraction of the newly synthesized FhlA to stay in solution. Cells were harvested at 4 mC and washed once with Tris buffer (50 mM Tris, pH 8n0; 0n5 mM EDTA ; 1 mM benzamidine ; 1 mM DTT). All subsequent operations were carried out at 4 mC. Cells were resuspended in 25 ml Tris buffer and broken by passage through a French pressure cell at 20 000 p.s.i. (138 MPa). The crude extract was centrifuged at 30 000 g for 2 h and the supernatant fraction was loaded onto Q-Sepharose column (30 cmi2n5 cm ; Pharmacia). The column was then washed with Tris buffer and the proteins were eluted with a linear gradient of NaCl (0-0n4 M) : the FhlA protein eluted at approximately 0n37 M NaCl. FhlA-containing fractions, as determined by SDS-PAGE analysis, were pooled and dialysed overnight in Tris buffer. This protein mixture was loaded onto a Hi-trap heparin column (Pharmacia) and eluted using a linear NaCl gradient (0-0n4 M) : the FhlA protein eluted at approximately 0n3 M NaCl. FhlA-containing fractions were pooled and dialysed overnight in HEPES buffer (30 mM HEPES, pH 7n0 with 0n5 mM EDTA, 1 mM benzamidine and 1 mM DTT). The FhlA protein was further purified using a 1 ml High S column (cation exchange, Bio-Rad) equilibrated with HEPES buffer and eluted with a linear gradient of 0-0n5 M NaCl. The FhlA protein eluted at approximately 0n25 M NaCl. Fractions containing FhlA protein were pooled and dialysed overnight in HEPES buffer. The final purification step required chromatography on a 1 ml High Q column (anion exchange, Bio-Rad) equilibrated with HEPES buffer and elution with a linear gradient of sodium citrate (0-0n3 M). The pure FhlA protein, as judged by SDS-PAGE analysis, was dialysed in storage buffer (25 mM HEPES, pH 7n0; 0n8 mM Effector-independent expression of hyc in E. coli DTT ; 10 % glycerol). FhlA protein was quickly frozen in liquid nitrogen and stored at k70 mC, in aliquots. Enzyme assay. FHL activities [expressed as nmol (mg cell protein) − " min − "] of late-exponential phase cultures were determined as described by Lee et al. (1985) . All experiments were carried out with whole cells to minimize O # inactivation of the enzyme. β-Galactosidase activities [expressed as nmol (mg cell protein) − " min − "] were determined in late-exponentialto early-stationary-phase cultures as described by . ATPase activity. ATPase activity associated with the FhlA protein was determined as described by Korsa & Bo$ ck (1997) , and expressed as pmol ATP hydrolysed (pmol FhlA) − ". DNA electrophoretic mobility-shift experiments. DNA mobility-shift experiments were performed essentially as described by Grunden et al. (1996) . Briefly, DNA containing the hyc-hyp intergenic region was PCR-amplified from plasmid pFGH100, using two primers : 5h-CCGGATCCGT-TATTTCGAGCATATC-3h and 5h-CCCTGCAGTTTAAG-CTAAAGATGAA-3h. This amplified DNA fragment, after digestion with PstI and BamHI, was cloned into plasmid pUC19, also digested with PstI and BamHI. The resulting plasmid, pWS40, was the source of a 154 bp PstI-BamHI fragment used in the electrophoretic mobility-shift experiments. The 154 bp DNA fragment, after isolation from a 10-30 % sucrose gradient, was labelled with $#P-dNTPs by filling in the recessed 3h end of the BamHI site with the DNA polymerase Klenow fragment. FhlA or FhlA165 protein was pre-incubated in binding buffer (10 mM Tris, pH 7n5; 1 mM EDTA ; 1 mM DTT ; 1 mM ATP) for 5 min at 4 mC before the labelled DNA was added. Binding reaction mixtures (total volume 20 µl) were incubated for 20 min at 37 mC. Polyacrylamide gels (5 %) were pre-run (100 V, 60 min, room temperature), with circulation of TBE buffer (Tris, 89 mM, pH 8n3 ; borate, 89 mM ; EDTA, 2n5 mM). Samples were loaded and the gels were run for a further 60 min (100 V), in TBE buffer. Buffer circulation re-started after the samples had been loaded. The gels were then dried and exposed to preflashed X-ray film. The band intensity was determined using a phosphorimager (Molecular Dynamics). Materials. Biochemicals were purchased from Sigma. Other organic and inorganic chemicals were from Fisher Scientific and were of analytical grade. Restriction endonucleases and DNA-modifying enzymes were purchased from Promega and New England Biolabs.
RESULTS AND DISCUSSION

Isolation of deletions within the N-terminal domain of FhlA
A number of deletion derivatives of fhlA which allowed the production of dihydrogen by an fhlA mutant strain, E. coli SE1174 (fhlA : :Tn10) were isolated. After analysis of the size of the fhlA gene in these plasmids and screening for the ability to support FHL production, four fhlA mutations with large deletions within the unique N-terminal domain of FhlA were selected for further analysis. Based on DNA sequence data, all four alleles (fhlA164, ∆26-370, L371V ; fhlA165, ∆5-374 ; fhlA166, ∆36-314 ; fhlA167, ∆1-117) carried large deletions in the unique N-terminal domain of FhlA. Although fhlA164 and fhlA166 supported production of FHL activity in a fhlA mutant, the level of hyc-lac expression in the presence of these two alleles was only (Fig. 1) , were studied in detail.
FhlA165 and FhlA167 are formate and molybdate independent
In the presence of native FhlA protein (pWS2), the optimum level of hyc-lac expression required both molybdate and formate ( Leonhartsberger et al. (2000) .
The FhlA167 mutant carried a deletion of amino acids 1-117, while the deletion in FhlA165 was of amino acids 5-374. These results show that removal of the first 117 aa is sufficient to produce an effector-independent transcriptional activator, but that this is not sufficient to overcome the inhibitory effect of the N-terminal domain of FhlA on the transcription of the hyc operon by the Cterminal domain. The critical structure responsible for modulating the activity of the C-terminal DNA-binding domain appears to reside between amino acids 118 and 374.
The product of the first gene of the hyc operon, hycA, appears to act by negatively modulating the level of hyc operon expression (Sauter et al., 1992) . The nature of this apparent repression is yet to be determined. Even in the presence of FhlA165 protein as activator, hyc-lac expression was reduced by HycA by the same level as seen with the native FhlA protein (data not shown). These results suggest that the effect of HycA on hyc operon expression is independent of formate and molybdate.
FhlA165 and FhlA167 activate transcription of P hyc lacZ in a modE moeA double mutant Both ModE and MoeA proteins are required for the molybdate-dependent transcription of the hyc operon (Hasona et al., 1998b) . ModE was shown to be a secondary transcriptional activator and directly interacts with hyc promoter (P hyc ) DNA (Self et al., 1999) . The role of MoeA in this regulation is not known but it has been proposed that the FhlA protein binds the catalytic product of MoeA (activated molybdenum ; Hasona et al., 1998a) and modulates its activity (Self & Shanmugam, 2000) . Since FhlA165 and FhlA167 activated transcription of hyc-lacZ even in the absence of molybdate, the need for ModE and MoeA proteins for the expression of hyc-lac with these deletion derivatives was determined.
A modE moeA double mutant containing the native FhlA protein, strain WS198(pWS2), produced a measurable, but low, level of β-galactosidase activity (approximately 180 units) when cultured in L-broth containing glucose (Table 3) ; the addition of molybdate to the medium had no effect on hyc-lac expression. In contrast, the same double mutant containing the FhlA165 protein, E. coli strain WS198(pWS165), produced an approximately 15-fold more β-galactosidase activity (2600 units) : this level of activity is also approximately 2n2-fold higher than the activity of a mod + strain containing the native FhlA, strain WS127(pWS2 Effector-independent expression of hyc in E. coli 65-75 % of the value obtained with the mod + strain with these mutated forms of the FhlA proteins [WS127(pWS165) ; WS127(pWS167)]. This lower than expected value was apparently a consequence of the absence of ModE protein, a required secondary activator, since a mutation in modE alone accounted for this difference. In the presence of either FhlA165 or FhlA167 the moeA mutation had no effect on hyc-lac expression. These results show that the deletions in FhlA165 and FhlA167 overcame the need for the MoeAcatalysed product for hyc operon expression, but not that for ModE-Mo, a required secondary activator of the hyc operon.
In a separate study, expression of hyc-lac was found to be limited by the concentration of FhlA in the cell when the protein was produced from a chromosomal copy of fhlA (J. A. Maupin & K. T. Shanmugam, unpublished data) . Under the present experimental conditions, the amount of β-galactosidase activity produced by a culture carrying λWS1 (hyc-lac) and a chromosomal copy of fhlA + was approximately 600 units. This value did not change significantly when the fhlA + gene was introduced from a plasmid (pWS3 ; vector pBR322) in a pcnB mutant background which limits the copy-number of the plasmid (Lopilato et al., 1986) . In a pcnB + strain, the level of β-galactosidase activity produced by a culture carrying plasmid pWS2 (vector pACYC184), which contains fhlA + , was approximately 1300 units, and in the presence of plasmid pWS3 (vector pBR322) the level of β-galactosidase activity produced from hyc-lac increased further to approximately 3000 units. This observed copy-number effect is not related to the proposed antagonistic effect of HycA on hyc-lac expression (Sauter et al., 1992) , as the strain used in these experiments carries a deletion of the entire srl-fhlA region. In the experiments described above (Tables 2  and 3 ), the fhlA gene was present in a pBR322-based plasmid and it is possible that the observed independence from MoeA could be a result of overexpression of the fhlA mutant allele. However, it should be noted that in a modE background, the moeA mutation severely limited hyc-lac expression even in the presence of multiple copies of the fhlA gene. To rule out the effect of multiple copies of fhlA, hyc-lac expression was investigated in a pcnB mutant background with the fhlA165 allele.
When the overall level of hyc-lac expression was reduced to approximately 600-700 units β-galactosidase activity (in a pcnB mutant, strain WS244) in the presence of native FhlA, the requirement for ModE-Mo and MoeA for hyc-lac expression could be readily detected.
In the presence of FhlA165, the modE mutation reduced the level of hyc-lac expression by about 33 %. Even in a modE moeA double mutant, the level of hyc-lac expression catalysed by FhlA165 was only reduced by about 30 % compared to the corresponding isogenic moeA mutant, strain WS246. However, with FhlA165, a moeA mutation alone had a positive effect on hyc-lac expression (1n4-fold higher than with the native FhlA protein) in this pcnB mutant, in contrast to a negative effect of the moeA mutation (27 % lower) Bo$ ck et al. previously proposed that the lack of hyc operon expression during conditions of aerobic (O # ) or anaerobic respiration (nitrate) was due to a lack of sufficient levels of formate to interact with FhlA (Rossmann et al., 1991) . The formate-independence of hyc-lacZ expression in the presence of FhlA165 and FhlA167 should lead to the production of significant β-galactosidase activity even under aerobic growth conditions. Strain WS127(pWS2) with wild-type fhlA + did not produce β-galactosidase activity when grown under aerobic growth conditions (Table 4) . Addition of formate to the medium increased the level of β-galactosidase activity only to approximately 200 units and this represents 21 % of the anaerobic level (Table  4) . Exogenously added formate appears to be unable to support hyc expression to an optimum level when the cells are cultured under aerobic conditions. Even in the presence of O # , P hyc lacZ was activated by FhlA165 protein to a level higher than that of the wild-type strain grown anaerobically in L-broth containing glucose (1600 and 1200 units β-galactosidase activity, respectively). However, the level of β-galactosidase activity produced by WS127(pWS165) was still only about 50 % of the same strain grown under anaerobic conditions. Including formate in the aerobic growth medium did not increase the level of P hyc lacZ expression in the presence of FhlA165. Since FhlA165 is formate-independent for the transcription of the hyc operon, this O # effect could be due to a reduction in the expression of the fhlA gene. Previous work from our laboratory showed that fhlAlacZ expression under aerobic growth conditions is only approximately 15 % of the values obtained with anaerobic cultures (J. A. Maupin & K. T. Shanmugam, unpublished data) . Recently, the oxyS small RNA species was shown to play a role in the regulation of fhlA, and this could account for O # -dependent control of the fhlA and fhlA165 genes (Altuvia et al., 1998) which indirectly controls the level of FHL in the cell. However, transducing an oxyS deletion mutation into strain WS127 did not affect the level of expression of hyc-lac or fhlA-lac in the presence of O # (data not shown). There appears to be an as yet unidentified O # - (Maupin & Shanmugam, 1990 ; Schlensog & Bo $ ck, 1990) ; PotA (Kashiwagi et al., 1993) ; ModF (Grunden et al., 1996) ; MalK (Shuman & Silhavy, 1981) ; XylG (Rosenfeld et al., 1984) ; LivG (Adams et al., 1990) ; HisP (Ames & Lever, 1970) ; ModC ; PotG (Pistocchi et al., 1993) .
dependent control of the hyc operon in E. coli. Although both the native FhlA and FhlA165 are produced to the same level in the cell, it is possible that there is a difference in the affinity of the two proteins for the P hyc which may account for the difference in the level of expression of hyc-lac in the aerobic cell.
As formate is also an electron donor for nitrate reduction, the presence of nitrate in vivo is expected to decrease the formate pool and consequently reduce the expression of the hyc operon. As expected, hyc-lacZ was expressed at a very low level in the presence of nitrate when native FhlA served as the activator (Table   4 ). Supplementing the medium with formate restored hyc-lacZ expression. However, with FhlA165 as the activator, nitrate had no detectable effect on the expression of the hyc operon, supporting the model that formate is not a required effector for FhlA165.
It is interesting to note that although FhlA167 supported effector-independent expression of hyc-lac when the cells were grown anaerobically, in an aerobic cell this allele supported the production of only approximately 200 units β-galactosidase activity (approximately 15 % of the anaerobic level). The addition of formate to the medium had a minimal effect on FhlA167-mediated hyc expression in the aerobic cell : this is in agreement with its formate independence. Addition of nitrate to the anaerobic culture also reduced the hyc-lac expression in the presence of FhlA167, but the nitrate effect was minimal compared to that of O # . This difference in the response of FhlA165 and FhlA167 to terminal electron acceptors suggests that the amino acids between 117 and 374 play a significant role in sensing the redox properties of the environment. Alternatively, the affinity of the two proteins for the P hyc may be different.
A sequence in the N-terminal region of FhlA is similar to a conserved region in ATPases of ABC transporters
As the first 117 amino acids of FhlA had been shown to be responsible for effector-mediated control of the hyc operon, this region of the FhlA sequence was compared with the sequences of other known E. coli proteins. This comparison revealed significant similarity between the N-terminal amino acid sequence of FhlA and sequences found in the energizer proteins of ABC transporters (Fig.  2) . The C-terminal end of the presented ABC protein sequences corresponds to the ' Walker ' B site, and the Nterminal end represents the unique ABC signature sequence (Linton & Higgins, 1998) . Upstream of this Effector-independent expression of hyc in E. coli ATPase-like sequence resides a helical domain which interacts with the membrane component of the ABC transport system (Hunke et al., 2000) . Although the critical aspartate and proline amino acids, present in all ' Walker ' B sites of the ABC proteins and the unique ABC signature sequence, were not present in the FhlA protein 18 of the 31 amino acids within this sequence (between amino acids 7 and 37) were similar or identical to a derived consensus sequence of the ABC proteins (Fig. 2) . The observed sequence similarity between the FhlA and ABC-ATPases raised interesting questions about the role of this N-terminal region of the FhlA protein. Does this region of FhlA along with the central domain of the protein contribute to formate-dependent ATP hydrolysis ? However, it should be noted that the N-terminal domain of FhlA by itself has no detectable ATPase activity (Leonhartsberger et al., 2000) .
To evaluate the significance of the N-terminal region of the FhlA protein, the DNA sequence corresponding to the amino acids 7-37 was deleted from the fhlA gene, and the resulting fhlA9-2 allele was used in hyc-lac expression studies (Fig. 1) . The fhlA9-2 allele failed to support hyc expression or production of FHL activity, even when the medium was supplemented with formate at levels as high as 30 mM and\or 1 mM molybdate. These results show that this segment of the FhlA protein is critical for in vivo activity of the FhlA protein. It is possible that the FhlA9-2 protein is still formatedependent for its activity and the inability to produce a FhlA9-2-formate complex in vivo apparently negated its activity. Removal of an additional 80 amino acids (to amino acid 117) completely reversed this defect, as FhlA167 is formate-independent (Fig. 1, Table 2 ).
Production of active FHL is independent of formate in the presence of FhlA165
Since transcription of the hyc operon was at its highest in the presence of FhlA165, the need for formate in the conversion of apo-FDH-H to active FDH-H was determined. Strain SE2007, which carries a mutation in the chromosomal fhlA gene, produced approximately 125 units FHL activity with plasmid pWS165. This value was slightly higher than the 110 units FHL activity produced by strain SE2007(pWS2) with wild-type fhlA. However in a fhlA\pfl double mutant, only the strain carrying fhlA165 produced FHL activity (approximately 90 units), again confirming the formate-independence for hyc and fdhF expression in the presence of FhlA165. These results further demonstrate that formate is only required for transcriptional activation of fdhF and hyc, and not for maturation and activation of the apoproteins to activate the FHL. of the P hyc DNA and completely shifted the DNA at a concentration of 1 µM FhlA (Fig. 3) . In contrast, the FhlA165 protein shifted the mobility of the DNA at a concentration of 100 nM and completely shifted the DNA at 500 nM FhlA165, suggesting that FhlA165 had a higher affinity for the target DNA sequence. Based on phosphorimager analysis of the DNA electrophoretic mobility shift presented in Fig. 3 , the apparent K d for the binding of FhlA165 to DNA was calculated to be 125 nM, while the value for the native FhlA protein was 270 nM. In similar mobility shift experiments, including formate in the binding reaction had no effect on the apparent K d of the interaction between DNA and protein (data not shown). The higher affinity of FhlA165 for the P hyc DNA could explain the higher level of hyc operon expression seen in the presence of the FhlA165 protein (Tables 2 and 4) , compared to the level of expression when activated by native FhlA. However, it could not be ruled out that FhlA165 had an increased ability to activate transcription.
FhlA167 had a very low affinity for P hyc DNA (Fig. 3D) , although this allele activated hyc-lac to the same level as the native protein, in vivo. The addition of formate to the binding reaction or to the electrophoresis conditions had no effect on the FhlA167-P hyc DNA interaction. In contrast, the FhlA9-2 allele, which did not support hyc operon expression, did bind to the P hyc DNA in vitro and shifted the electrophoretic mobility of the P hyc DNA (Fig. 3C ). This change in the electrophoretic mobility of the P hyc DNA saturated at a protein concentration of approximately 100 nM FhlA9-2, and at this concentration only a small fraction of the total DNA was protein-bound. At a protein concentration of 150 nM, most of the DNA was found in larger DNAprotein complexes.
ATPase activity of FhlA mutant derivatives
Members of the NtrC\NifA family of proteins including FhlA have a promoter DNA-dependent ATPase activity (Weiss et al., 1991 ; Hopper & Bo$ ck, 1995) . This activity is associated with the formation of the DNA-open complex, a prelude to the initiation of transcription (Wedel & Kustu, 1995) . Since the FhlA protein alleles had differing in vivo activities and promoter DNAbinding characteristics, the P hyc -dependent ATPase activity of the various FhlA alleles was determined.
Purified native FhlA protein had a basal ATPase activity of 250 units (Fig. 4) . This activity increased to 320 units in the presence of formate, and the optimum concentration of formate was between 10 and 25 mM. At 50 mM formate, the ATPase activity of FhlA protein decreased. In the presence of P hyc DNA the ATPase activity of the FhlA protein increased by over 200 pmol ATP hydrolysed (pmol FhlA) −" (approximately 25 mM formate present) (Fig. 4a) . This characteristic formateand DNA-dependent increase in ATPase activity of the FhlA protein is similar to that reported by Hopper & Bo$ ck (1995) .
The basal ATPase activity of the FhlA165 protein was only 60 pmol ATP hydrolysed (pmol FhlA) −" (Fig. 4) , and as expected this activity was not increased by formate. In the presence of P hyc DNA, the level of ATPase activity also increased by approximately 200 pmol ATP hydrolysed (pmol FhlA) −" . In contrast to the native protein, which responded positively to lower concentrations of formate, the FhlA165 reacted negatively to formate in the ATPase assay. The negative response to formate seen in vitro could also account for the formate-dependent decrease in hyc-lacZ activation in the mod mutant, strain WS113(pWS165) ( Table 2 ). The similar response of ATPase activity of the native FhlA and FhlA165 proteins to DNA suggested that these proteins, once bound to the hyc upstream DNA, activated transcription at the same level, and the observed difference in the hyc operon expression could be attributed to the differences in the affinity of the proteins to the P hyc DNA.
In these experiments the native FhlA protein had a higher than expected basal ATPase activity. This is in contrast to the ATPase activity of FhlA protein reported by Hopper & Bo$ ck (1995) . This difference could be due to variations in the protein purification methods employed in these two studies. The absence of formatedependent ATPase activity in FhlA165 suggested that the deletion of the unique N-terminal domain of FhlA removed a previously unknown ATPase activity, which may be specific for formate binding.
The FhlA167 protein had an ATPase activity of approximately 300 units which was not altered either by formate or by P hyc DNA. This is in agreement with its lower affinity to P hyc DNA (Fig. 4b) . The FhlA9-2 protein also produced approximately 300 pmol ATP hydrolysed (pmol FhlA) −" ATPase activity which was not influenced by the presence of formate. However, the ATPase activity of this protein increased by more than threefold in the presence of P hyc DNA. Addition of both P hyc DNA and formate to the reaction further increased the ATPase activity of the FhlA9-2 protein by twofold. In the presence of 10 mM formate and P hyc DNA the ATPase activity was over 1500 pmol ATP hydrolysed (pmol FhlA) −" , the highest among the four FhlA alleles tested.
Increasing the formate concentration beyond 10 mM inhibited the DNA-dependent ATPase activity. The ability of FhlA9-2 to bind to P hyc DNA in vitro and to hydrolyse ATP in a DNA-dependent manner shows that the FhlA9-2 protein is active in vitro. The formatedependent increase in ATPase activity of this allele is similar to that of the native FhlA protein and is in contrast to that of FhlA165 and FhlA167. These results suggest that the FhlA9-2 protein requires formate for activity and the FhlA9-2-formate complex is not formed in vivo because of the deletion of the amino acids 7-37. The inability of the FhlA9-2 protein to activate the expression of the hyc operon in vivo combined with the higher than expected activity in vitro raises the possibility that the fhlA9-2 is not transcribed in vivo. To test this, the upstream region of the fhlA gene in both pWS9 and pWS9-2 was sequenced. The two sequences were identical for approximately 500 bases upstream of the translation start site. In a separate experiment, total RNA was isolated from strains carrying either pWS9-2 or its parent pWS9 grown under anaerobic conditions in L-broth containing glucose (0n3%). A cDNA corresponding to the fhlA gene was synthesized from both samples using Moloney Murine Leukaemia virus reverse transcriptase (Superscript II ; Life Technologies). The cDNA was quantitated by real-time PCR using SYBR green (iCycler ; Bio-Rad). The results of these experiments showed that the level of cDNA produced from the total RNA from strains with plasmid pWS9 or pWS9-2 was comparable, indicating that the fhlA9-2 allele was also transcribed in E. coli. The inability to activate the hyc operon is apparently due to the deletion of amino acids in the protein.
CONCLUSION
Results from this study show that removal of the first 117 amino acids from the FhlA protein (FhlA167) leads to effector-independence for expression of the hyc operon. Extending the deletion to amino acid 374 (FhlA165) increases the ability of the protein to bind P hyc DNA in vitro, enhances the level of hyc operon expression in vivo, and also overcomes the redoxdependent control of hyc operon expression. 
